SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-02-007796
Filing Date
2002-08-13
Accepted
2002-08-13 10:02:33
Documents
6
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 REGENERON PHARMACEUTICALS, INC. y62778e10vq.htm 10-Q 309951
3 EX-10.22: FOCUSED COLLABORATION AGREEMENT y62778exv10w22.txt EX-10.22 158867
4 LICENSE AGREEMENT y62778exv10w23.txt EX-10.23 99415
5 EX-99.1: CERTIFICATION OF CEO AND CFO y62778exv99w1.htm EX-99.1 3060
6 GRAPHIC y62778xbox.gif GRAPHIC 1268
7 GRAPHIC y62778box.gif GRAPHIC 1219
  Complete submission text file 0000950123-02-007796.txt   575821
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 02728091
SIC: 2834 Pharmaceutical Preparations